APA (7th ed.) Citation

A, W., C, K., D, L., MP, M., FC, L., AC, S., . . . JA, D. (2026). Efficacy of the serogroup B Neisseria meningitidis vaccine (4CMenB) in preventing experimental Neisseria gonorrhoeae urethral infection: A double-blind randomised controlled human challenge study protocol. BMJ open, 16(4), e115296. https://doi.org/10.1136/bmjopen-2025-115296

Chicago Style (17th ed.) Citation

A, Waltmann, Kronk C, Lapple D, Motley MP, Lin FC, Seña AC, Hobbs MM, and Duncan JA. "Efficacy of the Serogroup B Neisseria Meningitidis Vaccine (4CMenB) in Preventing Experimental Neisseria Gonorrhoeae Urethral Infection: A Double-blind Randomised Controlled Human Challenge Study Protocol." BMJ Open 16, no. 4 (2026): e115296. https://doi.org/10.1136/bmjopen-2025-115296.

MLA (9th ed.) Citation

A, Waltmann, et al. "Efficacy of the Serogroup B Neisseria Meningitidis Vaccine (4CMenB) in Preventing Experimental Neisseria Gonorrhoeae Urethral Infection: A Double-blind Randomised Controlled Human Challenge Study Protocol." BMJ Open, vol. 16, no. 4, 2026, p. e115296, https://doi.org/10.1136/bmjopen-2025-115296.